- Report
- August 2025
- 187 Pages
Global
From €3219EUR$3,545USD£2,759GBP
€3577EUR$3,939USD£3,066GBP
- Report
- August 2025
- 193 Pages
Global
From €3219EUR$3,545USD£2,759GBP
€3577EUR$3,939USD£3,066GBP
- Report
- August 2025
- 186 Pages
Global
From €3219EUR$3,545USD£2,759GBP
€3577EUR$3,939USD£3,066GBP
- Report
- August 2025
- 197 Pages
Global
From €3219EUR$3,545USD£2,759GBP
€3577EUR$3,939USD£3,066GBP
- Report
- August 2025
- 187 Pages
Global
From €3219EUR$3,545USD£2,759GBP
€3577EUR$3,939USD£3,066GBP
- Report
- August 2025
- 194 Pages
Global
From €3219EUR$3,545USD£2,759GBP
€3577EUR$3,939USD£3,066GBP
- Report
- August 2025
- 182 Pages
Global
From €3219EUR$3,545USD£2,759GBP
€3577EUR$3,939USD£3,066GBP
- Report
- August 2025
- 180 Pages
Global
From €3219EUR$3,545USD£2,759GBP
€3577EUR$3,939USD£3,066GBP
- Report
- August 2025
- 188 Pages
Global
From €3219EUR$3,545USD£2,759GBP
€3577EUR$3,939USD£3,066GBP
- Report
- August 2025
- 192 Pages
Global
From €3219EUR$3,545USD£2,759GBP
€3577EUR$3,939USD£3,066GBP
- Report
- June 2026
- 200 Pages
Global
From €2715EUR$2,990USD£2,327GBP
- Report
- April 2026
- 200 Pages
Global
From €2715EUR$2,990USD£2,327GBP
- Report
- August 2025
- 200 Pages
Global
From €2261EUR$2,490USD£1,938GBP
- Report
- April 2026
- 200 Pages
Global
From €2715EUR$2,990USD£2,327GBP
- Report
- October 2025
Global
From €4449EUR$4,900USD£3,814GBP
- Report
- February 2026
Global
From €4449EUR$4,900USD£3,814GBP
- Report
- April 2026
- 138 Pages
Global
From €2723EUR$2,999USD£2,334GBP
€3631EUR$3,999USD£3,113GBP
- Report
- April 2026
- 138 Pages
Global
From €2723EUR$2,999USD£2,334GBP
€3631EUR$3,999USD£3,113GBP
- Report
- April 2026
- 146 Pages
Global
From €2723EUR$2,999USD£2,334GBP
€3631EUR$3,999USD£3,113GBP
- Report
- May 2026
- 140 Pages
Global
From €5402EUR$5,950USD£4,631GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more